Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor

[1]  A. Folsom,et al.  Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. , 2002, Journal of the National Cancer Institute.

[2]  N. Shinomiya,et al.  Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. , 2000, Anticancer research.

[3]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[4]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[5]  C. Compton,et al.  Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. , 2000, Annals of surgery.

[6]  A. Hsu,et al.  The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* , 2000, The Journal of Biological Chemistry.

[7]  D. Heilman,et al.  Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. , 2000, Carcinogenesis.

[8]  F. Sinicrope,et al.  Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. , 1999, Cancer research.

[9]  M. Monden,et al.  Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  M. Imamura,et al.  Characterization of six cell lines established from human pancreatic adenocarcinomas , 1999, Cancer.

[11]  M. Matsushita,et al.  Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. , 1998, Japanese journal of pharmacology.

[12]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[13]  S. Arii,et al.  Involvement of matrix metalloproteinase‐2 activity in invasion and metastasis of pancreatic carcinoma , 1998, Cancer.

[14]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. , 1998, Cancer research.

[15]  T. Tanaka,et al.  Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats , 1997, Inflammation Research.

[16]  C. Paraskeva,et al.  Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[19]  J. Morrow,et al.  Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. , 1994, The Journal of clinical investigation.

[20]  R. Hardman,et al.  Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. , 1993, Archives of biochemistry and biophysics.

[21]  David A Jones,et al.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.

[22]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Kohn,et al.  Cancer invasion and metastases. , 1990, JAMA.

[24]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[25]  C. Rüegg,et al.  NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. , 2001, Nature medicine.

[26]  H. Friess,et al.  Role of MT‐MMPs and MMP‐2 in pancreatic cancer progression , 2000, International journal of cancer.

[27]  K. Schrör,et al.  Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.

[28]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[29]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.